Next Generation Research Grant in ALS and Related Disorders
Next Generation Research Grant in ALS and Related Disorders supports early-career clinician-investigators studying disease mechanisms, diagnosis, or treatment to advance progress across these and other diseases.
Browse similar grants
Funder: American Brain Foundation
Due Dates: October 8, 2026, at 5:00 PM CT (Application) | March 2027 (Anticipated announcement) | July 1, 2027 (Award start) | June 30, 2029 (Award end)
Funding Amounts: $150,000 over two years ($75,000 per year); indirect costs not supported
Summary: Supports early-career clinician-investigators conducting clinical or preclinical research on ALS and related disorders with potential relevance to other diseases.
Key Information: Applicants must have completed clinical residency or a PhD in 2022 or later and have 70% protected research time.
Description
Funded by the CReATe Consortium and American Brain Foundation and administered by the foundation, this two-year grant supports early-career investigators studying disease mechanisms, diagnosis, or treatment. Eligible research covers ALS, progressive muscular atrophy, primary lateral sclerosis, frontotemporal dementia, hereditary spastic paraplegia, and multi-system proteinopathy.
The program supports clinical or preclinical research with potential relevance beyond these disorders, reflecting the foundation’s Cure One, Cure Many philosophy that breakthroughs in one area can accelerate progress across others. It emphasizes scientific rigor, innovation, clinical impact, and translational value, alongside mentorship and career development toward research independence. The foundation also encourages broad research perspectives and study populations reflecting the full spectrum of people affected by ALS and related disorders.
